Markus Cornberg

24.3k total citations · 2 hit papers
399 papers, 10.8k citations indexed

About

Markus Cornberg is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Markus Cornberg has authored 399 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 332 papers in Hepatology, 270 papers in Epidemiology and 67 papers in Immunology. Recurrent topics in Markus Cornberg's work include Hepatitis C virus research (289 papers), Hepatitis B Virus Studies (183 papers) and Liver Disease Diagnosis and Treatment (181 papers). Markus Cornberg is often cited by papers focused on Hepatitis C virus research (289 papers), Hepatitis B Virus Studies (183 papers) and Liver Disease Diagnosis and Treatment (181 papers). Markus Cornberg collaborates with scholars based in Germany, United States and Sweden. Markus Cornberg's co-authors include Heiner Wedemeyer, Michael P. Manns, Liisa K. Selin, Katja Deterding, Raymond M. Welsh, Thomas Berg, Benjamin Maasoumy, Stephen N. Waggoner, Jerzy Jaroszewicz and Birgit Bremer and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Markus Cornberg

374 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Acute Hepatitis C with Interferon Alfa-2b

2001 516 citations Elmar Jaeckel, Markus Cornberg et al. profile →
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection

2025 33 citations Markus Cornberg, Jerzy Jaroszewicz et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Markus Cornberg

Since Specialization

Citations

This map shows the geographic impact of Markus Cornberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Cornberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Cornberg more than expected).

Fields of papers citing papers by Markus Cornberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Cornberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Cornberg. The network helps show where Markus Cornberg may publish in the future.

Co-authorship network of co-authors of Markus Cornberg

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Cornberg. A scholar is included among the top collaborators of Markus Cornberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Cornberg. Markus Cornberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Origin of Hypofunctional CD103 ⁺ NK Cells in Cirrhosis‐Associated Ascites 2025 ·European Journal of Immunology ·(unknown), Daniel Geanon, (unknown), Marija Janković, Christopher Maucourant, (unknown), Ernesto Sparrelid, Heiner Wedemeyer, Julia Kahlhöfer, Christine S. Falk, Ildeu Andrade, Andrea Ponzetta, Niklas K. Björkström, Anke Kraft, Markus Cornberg, Benedikt Strunz	1
2	Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition 2024 ·Hepatology ·(unknown), (unknown), Manoj Kumar Gupta, (unknown), Birgit Bremer, (unknown), Katja Deterding, Benjamin Maasoumy, Heiner Wedemeyer, Cheng‐Jian Xu, Anke Kraft, Markus Cornberg	1
3	Attenuated effector T cells are linked to control of chronic HBV infection 2024 ·Nature Immunology ·Kathrin Heim, Sagar Sagar, Özlem Soğukpınar, Sian Llewellyn‐Lacey, David A. Price, Florian Emmerich, Anke Kraft, Markus Cornberg, (unknown), Percy A. Knolle, Dirk Wohlleber, Bertram Bengsch, Tobias Boettler, Christoph Neumann‐Haefelin, Robert Thimme, Maike Hofmann	24
4	Long‐term outcome of hepatitis delta in different regions world‐wide: Results of the Hepatitis Delta International Network 2024 ·Liver International ·Anika Wranke, (unknown), (unknown), George Ν. Dalekos, Mario Rizzetto, (unknown), Grazia Anna Niro, Onur Keskın, (unknown), (unknown), Patrick Ingiliz, Marion Muche, Marı́a Buti, Mathias Jachs, Thomas Vanwolleghem, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydın, (unknown), Heiner Wedemeyer, (unknown)	4
5	Deutlicher Anstieg neu diagnostizierter Hepatitis B- und Hepatitis C-Fälle nach Einführung des Screenings in die allgemeine Gesundheitsuntersuchung (ehemals „Check-up 35“) in Deutschland 2024 ·Zeitschrift für Gastroenterologie ·D Hüppe, (unknown), Markus Cornberg, Heiner Wedemeyer	0
6	Strategietreffen: Virushepatitis in Deutschland eliminieren – Was ist zu tun? 2023 ·Zeitschrift für Gastroenterologie ·Tammo Lambert Tergast, Ulrike Protzer, Stefan Zeuzem, (unknown), Christoph Sarrazin, (unknown), Patrick Ingiliz, Markus Cornberg, Ruth Zimmermann, (unknown), Peter Buggisch, (unknown), Heiner Wedemeyer	0
7	Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients 2023 ·Hepatology ·(unknown), (unknown), (unknown), (unknown), Sven Pischke, Thomas Horvatits, Julian Schulze zur Wiesch, Tobias Müller, Svenja Hardtke, Markus Cornberg, Heiner Wedemeyer, Patrick Behrendt, Eike Steinmann, Daniel Tödt	17
8	EASL Clinical Practice Guidelines on haemochromatosis 2022 ·Journal of Hepatology ·Heinz Zoller, Benedikt Schaefer, Annick Vanclooster, (unknown), Edouard Bardou‐Jacquet, Elena Corradini, Graça Porto, John Ryan, Markus Cornberg	76
9	Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper 2022 ·Journal of Hepatology ·Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, L Belli, Marina Berenguer, Marı́a Buti, Rajiv Jalan, Mario U. Mondelli, Richard Moreau, Daniel Shouval, Thomas Berg, Markus Cornberg	43
10	Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper 2020 ·JHEP Reports ·Tobias Boettler, Philip N. Newsome, Mario U. Mondelli, Mojca Matičič, Elisa Cordero, Markus Cornberg, Thomas Berg	346
11	UEG framework for the development of high‐quality clinical guidelines 2020 ·United European Gastroenterology Journal ·Doron Boltin, Doenja M. J. Lambregts, (unknown), (unknown), Stefanos Bonovas, Markus Cornberg, (unknown), Glen Doherty, (unknown)	7
12	Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver 2019 ·Cells ·Volker Kinast, (unknown), Richard J. P. Brown, Gabrielle Vièyres, Patrick Behrendt, (unknown), Pavel Strnad, Florian W. R. Vondran, Markus Cornberg, Cora Wex, Thomas Pietschmann, Johannes Haybaeck, Daniel Tödt, Eike Steinmann	6
13	Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells 2019 ·Journal of Hepatology ·Joana Dias, Julia Hengst, Tiphaine Parrot, Edwin Leeansyah, Sebastian Lunemann, David F. G. Malone, Svenja Hardtke, Otto Strauß, Christine L. Zimmer, Lena Berglin, (unknown), Sandra Ciesek, Nicole Marquardt, Thomas von Hahn, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Johan K. Sandberg, Niklas K. Björkström	64
14	A baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients with chronic hepatitis B 2018 ·Alimentary Pharmacology & Therapeutics ·Henry Lik‐Yuen Chan, Diethelm Messinger, George Papatheodoridis, Markus Cornberg, Qing Xie, Teerha Piratvisuth, Hong Ren, Patrick Kennedy, A. Thompson, (unknown), Georgios Bakalos, Vedran Pavlovic, Pietro Lampertico	22
15	Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity 2018 ·Nature Communications ·Benedikt Strunz, Julia Hengst, Katja Deterding, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Niklas K. Björkström	64
16	Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials 2016 ·Liver International ·Frank Tacke, Rainer Günther, Peter Buggisch, Hartwig Klinker, Andreas Schober, (unknown), Thomas A. Lutz, (unknown), Claus Niederau, Markus Cornberg, Christoph Sarrazin, Stefan Mauss	30
17	Improvement of liver function parameters in advanced HCV ‐associated liver cirrhosis by IFN ‐free antiviral therapies 2015 ·Alimentary Pharmacology & Therapeutics ·Katja Deterding, Christoph Höner zu Siederdissen, Kerstin Port, Philipp Solbach, (unknown), J. Kirschner, Carola Mix, (unknown), (unknown), Heiko Mix, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer	87
18	1232 INCREASED HEV SEROPREVALENCE IN PATIENTS WITH AUTOIMMUNE HEPATITIS 2013 ·Journal of Hepatology ·Sven Pischke, A. Gisa, Torsten Witte, (unknown), Birgit Bremer, R. Raupach, Patrick Lehmann, (unknown), Heike Bantel, Richard Taubert, Elmar Jaeckel, (unknown), Markus Cornberg, (unknown), Michael P. Manns, Heiner Wedemeyer	7
19	1159 SERUM ZINC BUT NOT SERUM VITAMIN D LEVELS ARE ASSOCIATED WITH DISEASE SEVERITY AND TREATMENT RESPONSE IN CHRONIC HEPATITIS C VIRUS INFECTION 2011 ·Journal of Hepatology ·(unknown), Kurt Grüngreiff, (unknown), Sebastian Lunemann, Jerzy Jaroszewicz, Markus Cornberg, M.P. Manns, Heiner Wedemeyer	3
20	Hepatitis D virus‐specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa‐treatment 2011 ·Liver International ·Jan Grabowski, Cihan Yurdaydın, Kalliopi Zachou, Peter Buggisch, Wolf Peter Hofmann, Jerzy Jaroszewicz, Verena Schlaphoff, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer, (unknown)	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact